{"entity":{"type":"insider","cik":"0001556327","url":"/insider/0001556327","json_url":"/insider/0001556327.json","name":"Kirby John J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":8,"first":"2020-01-10","last":"2026-08-18","span_basis":"filed_date"},"name_variants":[{"name":"Kirby John J.","source":"filing","n_filings":8,"first_seen":"2020-01-10","last_seen":"2026-08-18"}],"transactions":[{"id":9291606,"accession":"0001556327-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001556327-26-000003","line_url":"/filing/0001556327-26-000003#line-1","is_derivative":false,"issuer_cik":"0001556327","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001556327","owner_cik":"0001556327","owner_name":"Kirby John J.","owner_display_name":"Kirby John J.","owner_url":"/insider/0001556327","role":"Officer (Interim CFO)","role_mark":"O","role_mark_label":"Officer (Interim CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.93,"price_display":"4.93","price_state":"stated","total_value":24650.0,"total_display":"24,650.00","total_whole":"24,650","shares_owned_after":23962.0,"shares_owned_after_display":"23,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-18","scope":"insider"},{"id":4514461,"accession":"0001556327-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001556327-25-000004","line_url":"/filing/0001556327-25-000004#line-1","is_derivative":false,"issuer_cik":"0001556327","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001556327","owner_cik":"0001556327","owner_name":"Kirby John J.","owner_display_name":"Kirby John J.","owner_url":"/insider/0001556327","role":"Officer (Interim CFO)","role_mark":"O","role_mark_label":"Officer (Interim CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3536.0,"shares_display":"3,536","price_per_share":4.2425,"price_display":"4.24","price_state":"stated","total_value":15001.48,"total_display":"15,001.48","total_whole":"15,001","shares_owned_after":8962.0,"shares_owned_after_display":"8,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-25","scope":"insider"},{"id":4643108,"accession":"0001415889-21-006155","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-006155","line_url":"/filing/0001415889-21-006155#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":"0001556327","owner_name":"Kirby John J.","owner_display_name":"Kirby John J.","owner_url":"/insider/0001556327","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.615,"price_display":"0.62","price_state":"stated","total_value":6150.0,"total_display":"6,150.00","total_whole":"6,150","shares_owned_after":37632.0,"shares_owned_after_display":"37,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-17","filed_date":"2021-12-21","scope":"insider"},{"id":4926372,"accession":"0001415889-21-001670","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-001670","line_url":"/filing/0001415889-21-001670#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":"0001556327","owner_name":"Kirby John J.","owner_display_name":"Kirby John J.","owner_url":"/insider/0001556327","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6250.0,"shares_display":"6,250","price_per_share":1.4201,"price_display":"1.42","price_state":"stated","total_value":8875.625,"total_display":"8,875.62","total_whole":"8,876","shares_owned_after":27632.0,"shares_owned_after_display":"27,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-25","filed_date":"2021-03-29","scope":"insider"},{"id":5111743,"accession":"0001179110-21-000563","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-21-000563","line_url":"/filing/0001179110-21-000563#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":"0001556327","owner_name":"Kirby John J.","owner_display_name":"Kirby John J.","owner_url":"/insider/0001556327","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1693.0,"shares_display":"1,693","price_per_share":4.2243,"price_display":"4.22","price_state":"stated","total_value":7151.7399,"total_display":"7,151.74","total_whole":"7,152","shares_owned_after":33882.0,"shares_owned_after_display":"33,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-12","filed_date":"2021-01-12","scope":"insider"},{"id":5470359,"accession":"0001179110-21-000338","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-21-000338","line_url":"/filing/0001179110-21-000338#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":"0001556327","owner_name":"Kirby John J.","owner_display_name":"Kirby John J.","owner_url":"/insider/0001556327","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":862.0,"shares_display":"862","price_per_share":3.9,"price_display":"3.90","price_state":"stated","total_value":3361.8,"total_display":"3,361.80","total_whole":"3,362","shares_owned_after":35575.0,"shares_owned_after_display":"35,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-05","filed_date":"2021-01-06","scope":"insider"},{"id":9242580,"accession":"0001179110-20-000557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-000557","line_url":"/filing/0001179110-20-000557#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":"0001556327","owner_name":"Kirby John J.","owner_display_name":"Kirby John J.","owner_url":"/insider/0001556327","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":911.0,"shares_display":"911","price_per_share":1.7804,"price_display":"1.78","price_state":"stated","total_value":1621.9444,"total_display":"1,621.94","total_whole":"1,622","shares_owned_after":16437.0,"shares_owned_after_display":"16,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-07","filed_date":"2020-01-14","scope":"insider"},{"id":2938621,"accession":"0001179110-20-000448","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-000448","line_url":"/filing/0001179110-20-000448#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":"0001556327","owner_name":"Kirby John J.","owner_display_name":"Kirby John J.","owner_url":"/insider/0001556327","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":911.0,"shares_display":"911","price_per_share":1.7804,"price_display":"1.78","price_state":"stated","total_value":1621.9444,"total_display":"1,621.94","total_whole":"1,622","shares_owned_after":16437.0,"shares_owned_after_display":"16,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-07","filed_date":"2020-01-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001660334","name":"Verrica Pharmaceuticals Inc.","url":"/issuer/0001660334","role":"Officer (Interim CFO)","n_filings":2,"first_seen":"2025-11-25","last_seen":"2026-08-18"},{"type":"issuer","type_label":"ISSUER","cik":"0000861838","name":"IDERA PHARMACEUTICALS, INC.","url":"/issuer/0000861838","role":"Officer (CHIEF FINANCIAL OFFICER)","n_filings":6,"first_seen":"2020-01-10","last_seen":"2021-12-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001556327","retrieved_at":"2026-08-22T23:22:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}